Gene · 2683
B4GALT1: beta-1,4-galactosyltransferase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. B4GALT1: beta-1,4-galactosyltransferase 1. Genes, record 2683. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2683
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P15291 | Beta-1,4-galactosyltransferase 1 | 398 | 19 | Ensembl, GeneID, HGNC |
Source UniProt
Patents114
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4807367 A2 | 2026-09-16 | 37 | P15291 | Espacenet |
| EP 4774376 A1 | 2026-07-15 | 5 | P15291 | Espacenet |
| JP 2026067851 A | 2026-04-21 | 243 | P15291 | Espacenet |
| JP 2026067872 A | 2026-04-21 | 43 | P15291 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 69151 | P15291 | Espacenet |
| JP 2025540146 A | 2025-12-11 | 2 | P15291 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10511 | P15291 | Espacenet |
| JP 2025530569 A | 2025-09-11 | 4 | P15291 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 559 | P15291 | Espacenet |
| KR 1020250115388 A | 2025-07-30 | 2 | P15291 | Espacenet |
1 to 10 of 114
See all 114 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | B4GALT1 papers | Newest fiscal year |
|---|---|---|---|
| R01GM083144 | Characterization of mammalian COG complex-interacting Golgi trafficking machinery | 12 | 2025 |
| R01CA200423 | Chemical Glycoproteomics | 4 | 2025 |
| P01HL151333 | Molecular and Clinical Glycobiology of the Bone Marrow Environment | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| R01DK078244 | Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes | 3 | 2025 |
| R01HL089224 | Carbohydrate-Mediated Platelet Clearance | 3 | 2025 |
| R01HL103411 | Systems Biology of Glycosylation | 3 | 2025 |
| R24GM137782 | National Glycoscience Resource- CCRC Service and Training - NGlycoR@CCRC | 3 | 2025 |
| R35GM119850 | Unraveling the mammalian secretory pathway through systems biology and algorithm development | 3 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 3 | 2025 |
1 to 10 of 1,018Source NIH's project files
See all 1,018 nih grantsPapers1,884
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycosylation orchestrates megakaryocytic fate of hematopoietic stem cells via Wnt-MUC13 signaling. | Nat Commun | 2026 | 42733053 | PubTator, text mining | PubMed |
| Development and internal validation of a six-gene prognostic model based on galactose metabolism for overall survival in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42724461 | PubTator, text mining | PubMed |
| B3GNT5-associated glycosylation remodeling in tumor-associated macrophages supports TGF-β-related glioma progression. | Biochim Biophys Acta Gen Subj | 2026 | 42715804 | PubTator, text mining | PubMed |
| Programmable HMO biosynthesis enabled by human cell-based glycoengineering. | Glycobiology | 2026 | 42616032 | PubTator, text mining | PubMed |
| B4GALT1-related congenital disorder of glycosylation mimicking Ehlers-Danlos syndrome: a child with multisystem involvement and nephrotic syndrome. | Clin Exp Pediatr | 2026 | 42526876 | PubTator, text mining | PubMed |
| Kaposi Sarcoma Herpes Virus Reprograms Mesenchymal Cell Glycosylation to control platelet-derived growth factor receptor A signaling. | bioRxiv | 2026 | 42427740 | PubTator, text mining | PubMed |
| Biocatalytic C3 β-O-Glycosylation of Triterpenes and Sterols to Synthesize Natural and Unnatural Saponins. | J Am Chem Soc | 2026 | 42390099 | PubTator, text mining | PubMed |
| Chemoenzymatic synthesis of unusual antibody glycoforms using E. coli expressed human and bovine β-1,4-galactosyltransferase and their mutants. | Carbohydr Res | 2026 | 42378775 | PubTator, text mining | PubMed |
| Biosynthesis of human milk oligosaccharides (HMOs) in glycoengineered human cells. | Glycobiology | 2026 | 42324760 | PubTator, text mining | PubMed |
| Reconstitution of human milk oligosaccharide biosynthesis in cultured mammalian cells. | Metab Eng | 2026 | 42323078 | PubTator, text mining | PubMed |
1 to 10 of 1,884
See all 1,884 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2683
GET https://conductscience.org/api/genes/v1/2683/patents?page=2